about
Intravesical bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancerCell adhesion and urothelial bladder cancer: the role of cadherin switching and related phenomenaMultimodal 3D cancer-mimicking optical phantom.Long-term urodynamic evaluation of laparoscopic radical cystectomy with orthotopic ileal neobladder for bladder cancerProtein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM.Health-care services utilization and costs associated with radical cystectomy for bladder cancer: a descriptive population-based study in the province of Quebec, Canada.Combined HSP90 and kinase inhibitor therapy: Insights from The Cancer Genome Atlas.miR-199a-5p suppresses human bladder cancer cell metastasis by targeting CCR7.Gecko proteins induce the apoptosis of bladder cancer 5637 cells by inhibiting Akt and activating the intrinsic caspase cascadeRegulator of cullins-1 expression knockdown suppresses the malignant progression of muscle-invasive transitional cell carcinoma by regulating mTOR/DEPTOR pathway.Performance of simultaneous high temporal resolution quantitative perfusion imaging of bladder tumors and conventional multi-phase urography using a novel free-breathing continuously acquired radial compressed-sensing MRI sequenceCytokines as effectors and predictors of responses in the treatment of bladder cancer by bacillus Calmette-Guérin.CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer.Diagnostic Microdosing Approach to Study Gemcitabine Resistance.Regulation of metastasis of bladder cancer cells through the WNT signaling pathway.An Osteopontin/CD44 Axis in RhoGDI2-Mediated Metastasis SuppressionPredictors of costs associated with radical cystectomy for bladder cancer: A population-based retrospective cohort study in the province of Quebec, Canada.Quercetin induces bladder cancer cells apoptosis by activation of AMPK signaling pathway.Cohort profile: The Swedish National Register of Urinary Bladder Cancer (SNRUBC) and the Bladder Cancer Data Base Sweden (BladderBaSe)A novel synthetic derivative of quercetin, 8-trifluoromethyl-3,5,7,3',4'-O-pentamethyl-quercetin, inhibits bladder cancer growth by targeting the AMPK/mTOR signaling pathway.Urinary Protein Markers for the Detection and Prognostication of Urothelial Carcinoma.RIPK4 promotes bladder urothelial carcinoma cell aggressiveness by upregulating VEGF-A through the NF-κB pathway.
P2860
Q24188295-3E70BC14-7296-4477-8967-D01733860EDBQ26860953-D44645A5-E4A1-4998-9C3B-2A11783E3D54Q30388394-E9B4D19F-5854-4527-B468-E1EACAA847F3Q33967578-D4D95D6E-A5DA-4C90-B1BA-E9C0DCB3AEE9Q35198309-47D1DE52-C51B-4863-8DB2-B61EDB7B1E72Q35736201-DA950214-3902-4E3D-B66E-C2066F7E6F0EQ35930811-640294DE-D705-43D1-B2F0-51D682BC38D1Q36183239-A3439941-460D-4382-A679-15A27A5AB0B6Q36270006-E21FE8B2-082F-4316-B7FA-46819862EF8BQ36547894-C2E3BB02-979B-4618-8A10-AB95B3B85FFBQ36977504-847E8CB9-B692-468E-940A-EE3352F9F794Q38232854-36FAF92A-E3E2-4BC3-9E47-862876668084Q38741840-12381173-4DA4-486F-8D05-F42C7E88DE1EQ38744400-F86A083D-F7E5-446D-BFDD-6B8DCA2F3005Q38864687-E4CF38D5-0428-4F36-A9D2-7DAA9766B980Q39424176-728C4BF2-A167-436C-A31D-8C9F26E9B9A8Q41027602-41C5CCEB-88B7-420E-B58A-68963432634FQ41126640-4E3D9571-6FCF-41E6-8E8B-1F7B3EE82769Q42368645-C5D188BC-DE08-4868-846D-FD2996B84E7AQ42700909-DF2F4D22-A92F-4812-8697-324F5EAC4D6CQ47826917-AE710061-5E93-46EB-8898-FDA00D6E3ED1Q54977091-6DB6E0BB-30E5-480D-AD72-3C08FB29F6D0
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The future of bladder cancer care in the USA.
@en
type
label
The future of bladder cancer care in the USA.
@en
prefLabel
The future of bladder cancer care in the USA.
@en
P2093
P2860
P356
P1476
The future of bladder cancer care in the USA.
@en
P2093
Alan L Kaplan
Karim Chamie
Mark S Litwin
P2860
P2888
P356
10.1038/NRUROL.2013.180
P407
P577
2013-08-27T00:00:00Z
P6179
1021749834